Royce & Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-294,800	Closed	-$1.27M	–	1191
2019 Q3	$1.27M	Buy	294,800 +57,100	+24%	+$228K	0.01%	773
2019 Q2	$948K	Sell	237,700 -80,000	-25%	-$380K	0.01%	842
2019 Q1	$1.7M	Hold	317,700	–	–	0.01%	780
2018 Q4	$1.63M	Sell	317,700 -76,669	-19%	-$582K	0.01%	784
2018 Q3	$3.83M	Sell	394,369 -18,500	-4%	-$187K	0.03%	663
2018 Q2	$4.21M	Buy	412,869 +23,200	+6%	+$263K	0.03%	638
2018 Q1	$5.07M	Buy	389,669 +29,400	+8%	+$438K	0.04%	564
2017 Q4	$6.45M	Buy	360,269 +67,069	+23%	+$1.4M	0.04%	514
2017 Q3	$7.36M	Buy	293,200 +10,300	+4%	+$240K	0.05%	464
2017 Q2	$6.82M	Buy	282,900 +150,300	+113%	+$3.32M	0.05%	497
2017 Q1	$2.55M	Buy	+132,600	New	+$2.09M	0.02%	787